The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
III - Pulmonary/alveolar./airway hemorrhage/bleeding
VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
X - Systemic/Distant conditions, syndromes and reactions
DRES syndrome - DRESS-like reaction
Anaphylaxis-Anaphylactoid reaction (can be fatal)
Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
Vascultis (pulmonary, extrathoracic or systemic)-ANCA status unknown or negative)
Coagulopathy (See under IIIm)
Skin purpura, ecchymoses or necrosis
Thrombotic microangiopathy